With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? To what extent will the FDA reguate hemp-derived CBD?
High Times article by Martin A Lee highlights the breakthrough research on CBD, and how it has revolutionized the story of cannabis medicine.
Huge interest in the medicinal potential of CBD has catalyzed a rebirth of industrial hemp in the U.S. But is hemp the best source of CBD?
Numerous commercial start-ups have jumped on the CBD bandwagon. But along with a growing awareness of CBD as a potential health aid there has been a proliferation of misconceptions.
By defining cannabinoids as drugs that work at the CB1 and CB2 receptors (the canonical cannabinoid receptors concentrated in the central and peripheral nervous system), researchers may be overlooking beneficial compounds in cannabis that work by other mechanisms.